NODELMAN OLEG (CIK 1454385) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-12). Recent activity: Buy AKTS (2.3M shares), Buy AKTS (202,862 shares), Buy AKTS (128,506 shares), Buy AKTS (2.1M shares), Buy AKTS (144,443 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 2.3M | $0 |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 202,862 | $0 |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 128,506 | $0 |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 2.1M | $37.4M |
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 144,443 | $2.6M |
| 2025-06-27 | Zymeworks Inc. (ZYME) | Director | Buy | 5.1M | $0 |
| 2025-06-27 | Zymeworks Inc. (ZYME) | Director | Sell | 41 | $521 |
| 2025-05-19 | Zymeworks Inc. (ZYME) | Director | Buy | 49,502 | $565,808 |
| 2025-05-19 | Zymeworks Inc. (ZYME) | Director | Buy | 5,919 | $69,726 |
| 2025-04-18 | Zymeworks Inc. (ZYME) | Director | Buy | 73,953 | $825,315 |
| 2025-04-18 | Zymeworks Inc. (ZYME) | Director | Buy | 54,760 | $630,835 |
| 2025-04-07 | Zymeworks Inc. (ZYME) | Director | Buy | 120,770 | $1.4M |
| 2025-04-07 | Zymeworks Inc. (ZYME) | Director | Buy | 196,438 | $2.2M |
来源：SEC Form 4 申报文件 · 截至 2026-01-12